Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Regulatory News (HZD)

  • There is currently no data for HZD

Total Voting Rights

5 Apr 2018 07:00

RNS Number : 8682J
Horizon Discovery Group plc
05 April 2018
Β 

5 April 2018

Β 

Horizon Discovery Group plcΒ 

Β 

Total Voting Rights

Β 

In accordance with Disclosure and Transparency Rule 5.6.1 Horizon Discovery Group plc (the "Company") advises that:

Β 

As at 31 March 2018, the Company's issued share capital consisted of 149,091,182 ordinary shares of 1p each with voting rights. The Company does not hold any ordinary shares in Treasury.

Β 

The total number of voting rights in the Company is therefore 149,091,182.

Β 

The above figure (149,091,182) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Horizon Discovery Group plc under the FCA's Disclosure and Transparency Rules.

Β 

ENDS

Β 

For further information, please contact:

Β 

Horizon Discovery Group plc

Richard Vellacott, Interim Chief Executive Officer

Chris Claxton, VP Investor Relations

Tel: +44 (0) 1223 655 580

Β 

Numis Securities Limited (Broker and NOMAD)

Michael Meade / Freddie Barnfield

Tel: +44 (0)Β 207 260 1000

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TVRUGURPCUPRGQC
Date   Source Headline
18th Apr 20167:00 amRNSChange of Adviser
7th Apr 20167:00 amRNSNotice of Results
24th Mar 201612:29 pmRNSAdditional Listing
24th Mar 20168:54 amRNSAdditional Listing
15th Mar 20167:00 amRNSHorizon Discovery hosts symposium on gene editing
2nd Mar 20167:00 amRNSHorizon Discovery Group forms Immuno-oncology JV
26th Jan 20164:04 pmRNSHolding(s) in Company
22nd Jan 20161:21 pmRNSHolding(s) in Company
18th Jan 20167:00 amRNSTrading Update
15th Jan 20164:14 pmRNSAdditional Listing
12th Jan 201610:09 amRNSAdditional Listing
17th Dec 20159:52 amRNSDirector/PDMR Shareholding
11th Dec 20159:23 amRNSAdditional Listing
25th Nov 20157:00 amRNSThree diagnostic agreements worth an initial $3.3m
13th Nov 20157:00 amRNSDirector Dealings
12th Nov 20151:30 pmRNSBoard Change
12th Nov 20157:00 amRNSHolding(s) in Company
12th Nov 20157:00 amRNSHolding(s) in Company
6th Nov 20153:51 pmRNSDirector/PDMR Shareholding
29th Oct 20157:00 amRNSTotal Voting Rights
28th Oct 20157:00 amRNSNew E-Commerce Platform and UK Headquarters
21st Oct 20158:48 amRNSAdditional Listing
15th Oct 20155:44 pmRNSGrant of options under Long Term Incentive Plan
7th Oct 20154:00 pmRNSIssue of Equity
7th Oct 20157:00 amRNSIn-licensing agreement with Servier
22nd Sep 20157:00 amRNSHalf Yearly Report
18th Sep 201510:17 amRNSAdditional Listing
16th Sep 20157:00 amRNSCell Line Licensing Agreement with LakePharma Inc
9th Sep 20157:00 amRNSHZD & Abcam plc Sign License & Supply Agreement
3rd Sep 20157:00 amRNSCancer Research Collaboration with Redx Pharma
3rd Sep 20157:00 amRNSCancer Research Collaboration
1st Sep 201511:49 amRNSAdditional Listing
1st Sep 20157:04 amRNSNotice of Interim Results
27th Jul 20157:00 amRNSHZD To Invest c£10M In Cancer R&D
20th Jul 20157:00 amRNSTrading update
17th Jul 201512:34 pmRNSAdditional Listing
19th Jun 201511:28 amRNSResult of AGM
26th May 20154:46 pmRNS2014 Annual Report and Accounts & AGM Notification
22nd May 20153:28 pmRNSHolding(s) in Company
21st May 20156:04 pmRNSHolding(s) in Company
18th May 201511:50 amRNSResult of General Meeting and Issue of Equity
14th May 20157:00 amRNSDirectorate Change
5th May 20157:01 amRNSCorrection to Results of Placing
1st May 20154:15 pmRNSResults of Placing
1st May 201511:08 amRNSProposed placing and Notice of General Meeting
23rd Apr 20157:00 amRNSHORIZON AND TRANSGENOMIC SIGN OEM AGREEMENT
20th Apr 20157:00 amRNSHorizon & Thermo Fisher Scientific Sign Agreement
14th Apr 20157:07 amRNSPreliminary Results
10th Apr 20153:30 pmRNSAdditional Listing
27th Mar 20158:29 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.